GlaxoSmithKline PLC (NYSE:GSK)

44.91
BATS BZX Real-Time Price
As of 10:05am ET
 -0.16 / -0.36%
Today’s Change
36.41
Today|||52-Week Range
46.01
+17.53%
Year-to-Date
Is Clovis Oncology Really a Buyout Candidate?
Dec 03 / MotleyFool.com - Paid Partner Content
3 Top Growth Stocks to Buy in December
Dec 03 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close45.07
Today’s open45.07
Day’s range44.91 - 45.09
Volume974,647
Average volume (3 months)2,505,437
Market cap$113.5B
Data as of 10:05am ET, 12/05/2019

Growth & Valuation

Earnings growth (last year)+143.10%
Earnings growth (this year)+0.23%
Earnings growth (next 5 years)+4.40%
Revenue growth (last year)+5.72%
P/E ratio18.8
Price/Sales2.31
Price/Book20.16

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co-0.83-0.70%
SNYSanofi-0.29-0.62%
NVONovo Nordisk-0.17-0.30%
AZNAstraZeneca-0.37-0.77%
Data as of 10:05am ET, 12/05/2019

Financials

Next reporting dateFebruary 5, 2020
EPS forecast (this quarter)$0.69
Annual revenue (last year)$41.1B
Annual profit (last year)$4.8B
Net profit margin11.75%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Brentford, Greater London

Forecasts